Viridescent Capital Partners is a global investment management firm focused on making scalable, diversified investments in the cannabis industry.

Viridescent Capital Partners

HALLEY VP is a cannabis technology venture fund focused on investing early in scalable companies within the legal cannabis and hemp sectors.

HALLEY VP

Viridescent Capital Partners LP | 416 followers on LinkedIn. Viridescent Capital Partners is a private equity firm that brings extensive experience and flexible capital solutions to companies across the cannabis industry. 
 
Our executive team brings more than 60 years of combined capital markets experience and more than 20 years of operating and investing experience in the cannabis industry, making us a credible partner for investors looking to access the cannabis space. 
 
Our deep domain experience and understanding in cannabis make us a powerful ally for companies seeking a partner to foster growth and help facilitate company success through an extensive network that spans the cannabis value chain.

Founder & Chief Investment Officer at Viridescent Capital Partners LP

Kevin Murphy

Strategic Advisor for Viridescent Capital Partners LP

Drew Dawson

Head of Origination and Partner at Viridescent Capital Partners LP

Dennis Byrne

Chief Operating Officer and Partner at Viridescent Capital Partners LP

Dante Domenichelli

Viridescent Capital Partners LP

https://lnkd.in/gQbu_f5e The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use and a moderate to low potential for physical and psychological dependence. But what does this mean in the real world exactly? Sanjay talks with “The Pot Doc” Dr. Staci Gruber, Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program in Boston, to explore the possible impacts of this rescheduling on research, healthcare, and yes – even you.

Metric
Company Name	Viridescent Capital Partners	HALLEY VP
Symbol
MSH ID	COM:VIRIDESCENTCAPITAL	COM:HALLEYVP
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance
Industry	Investment Management	Venture Capital
Country	US	US
Stage
Employee Count
Website	viridescentcapital.com	halleyvp.com
LinkedIn	viridescent-capital-partners-lp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VIRI

COM:VIRIDESCENTCAPITAL

Viridescent Capital Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue